Concurrent to the exploration of Adeno-Associated Virus (AAV) used in clinical trials, optogenetics has been rapidly developing as a promising tool in cardiac electrophysiology research. Optogenetics depends on the genetic modification of cells and tissues to induce the expression of light-sensitive opsins for precise bi-directional control of activity.